Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?

Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?

Jennifer Swainson;Atul Khullar;
the journal of clinical psychiatry 2020 Vol. 81 pp. 0-0
160
swainson2020thesublingual

Abstract

In this letter to the editor, Drs Swainson and Khullar describe their experiences with use of sublingual ketamine in the clinical setting and argue that it may be an accessible alternative for appropriate patients.

Citation

ID: 114201
Ref Key: swainson2020thesublingual
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114201
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet